- Report
- October 2024
- 182 Pages
Global
From €3228EUR$3,545USD£2,776GBP
€3587EUR$3,939USD£3,085GBP
- Report
- April 2025
- 196 Pages
Global
From €5327EUR$5,850USD£4,582GBP
- Report
- April 2025
- 200 Pages
Global
From €4089EUR$4,490USD£3,516GBP
- Report
- February 2025
- 186 Pages
Global
From €4098EUR$4,500USD£3,524GBP
- Report
- May 2024
- 133 Pages
Global
From €5918EUR$6,499USD£5,090GBP
- Report
- June 2024
- 200 Pages
Global
From €7240EUR$7,950USD£6,226GBP
- Report
- October 2024
- 189 Pages
Global
From €3228EUR$3,545USD£2,776GBP
€3587EUR$3,939USD£3,085GBP
- Report
- October 2024
- 193 Pages
Global
From €3228EUR$3,545USD£2,776GBP
€3587EUR$3,939USD£3,085GBP
- Report
- March 2025
- 150 Pages
Global
From €5418EUR$5,950USD£4,660GBP
- Report
- April 2025
- 175 Pages
Global
From €4089EUR$4,490USD£3,516GBP
- Report
- May 2024
- 136 Pages
Global
From €5918EUR$6,499USD£5,090GBP
- Report
- January 2025
- 144 Pages
Global
From €3597EUR$3,950USD£3,093GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3415EUR$3,750USD£2,937GBP
- Report
- December 2021
- 245 Pages
Global
From €2504EUR$2,750USD£2,154GBP
€5009EUR$5,500USD£4,307GBP
- Report
- December 2023
- 130 Pages
Global
From €5418EUR$5,950USD£4,660GBP
- Report
- September 2023
- 180 Pages
Global
From €5418EUR$5,950USD£4,660GBP
- Report
- July 2023
- 130 Pages
Global
From €5418EUR$5,950USD£4,660GBP
- Report
- August 2022
- 117 Pages
Global
From €4098EUR$4,500USD£3,524GBP
- Report
- March 2024
- 120 Pages
Global
From €7240EUR$7,950USD£6,226GBP
- Report
- November 2023
- 30 Pages
Global
From €2960EUR$3,250USD£2,545GBP

The Influenza Drug market is a subset of the larger Respiratory Drug market, which includes treatments for a variety of respiratory illnesses, such as asthma, COPD, and cystic fibrosis. Influenza drugs are used to treat the symptoms of the flu, such as fever, cough, and sore throat. These drugs can also help reduce the risk of complications from the flu, such as pneumonia. Commonly used influenza drugs include antivirals, such as oseltamivir and zanamivir, and anti-inflammatory drugs, such as ibuprofen and acetaminophen.
Some companies in the Influenza Drug market include GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Other companies include Roche, Merck, and Pfizer. Show Less Read more